Chargement en cours...

Immune Effects of Bevacizumab: Killing Two Birds with One Stone

Angiogenesis or new vessel formation is essential for tumour growth and progression. Therefore, targeting angiogenesis has been an attractive strategy in the treatment ofcancer. Bevacizumab is a recombinant humanized monoclonal IgG1 antibody thattargets vascular endothelial growth factor-A (VEGF-A)...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Microenviron
Auteurs principaux: Elamin, Yasir Y., Rafee, Shereen, Toomey, Sinead, Hennessy, Bryan T.
Format: Artigo
Langue:Inglês
Publié: Springer Netherlands 2014
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4449343/
https://ncbi.nlm.nih.gov/pubmed/25326055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12307-014-0160-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!